| Trial ID: | L7035 |
| Source ID: | NCT01023945
|
| Associated Drug: |
Asp1941
|
| Title: |
A Study of ASP1941 in Japanese Patients With Type 2 Diabetes Mellitus
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: ASP1941|DRUG: Placebo
|
| Outcome Measures: |
Primary: Change in plasma glucose levels, On day 14 | Secondary: Urinary glucose excursion, On day 14|Pharmacokinetic parameter of ASP1941, On day 14|Safety by adverse events, routine safety laboratories and vital signs., During treatment|Change in serum insulin levels, On day 14
|
| Sponsor/Collaborators: |
Sponsor: Astellas Pharma Inc
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
30
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2009-11-07
|
| Completion Date: |
2010-03-26
|
| Results First Posted: |
|
| Last Update Posted: |
2024-11-12
|
| Locations: |
Kantou, Japan
|
| URL: |
https://clinicaltrials.gov/show/NCT01023945
|
